Microglial phenotypes in Parkinson's disease and animal models of the disease.
about
P2X4 Receptor Function in the Nervous System and Current Breakthroughs in Pharmacology.Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's DiseaseHerpes zoster correlates with increased risk of Parkinson's disease in older people: A population-based cohort study in Taiwan.Autophagy and Microglia: Novel Partners in Neurodegeneration and Aging.Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease.Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharide.The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson's disease.l-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?Outdoor Ambient Air Pollution and Neurodegenerative Diseases: the Neuroinflammation Hypothesis.Parkinson's disease: Microglial/macrophage-induced immunoexcitotoxicity as a central mechanism of neurodegenerationLocal Cues Establish and Maintain Region-Specific Phenotypes of Basal Ganglia Microglia.Is the Enzyme ACMSD a Novel Therapeutic Target in Parkinson's Disease?Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia.Microglia at center stage: a comprehensive review about the versatile and unique residential macrophages of the central nervous system.Intranasal Administration of TAT-Conjugated Lipid Nanocarriers Loading GDNF for Parkinson's Disease.CDK11p58 Promotes Microglia Activation via Inducing Cyclin D3 Nuclear Localization.Boosting phagocytosis and anti-inflammatory phenotype in microglia mediates neuroprotection by PPARγ agonist MDG548 in Parkinson's disease.Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson's Disease?Regional microglia are transcriptionally distinct but similarly exacerbate neurodegeneration in a culture model of Parkinson's disease.Osteocalcin Ameliorates Motor Dysfunction in a 6-Hydroxydopamine-Induced Parkinson's Disease Rat Model Through AKT/GSK3β SignalingCerebrospinal fluid pro-inflammatory cytokines differentiate parkinsonian syndromesMicroglia Response During Parkinson's Disease: Alpha-Synuclein Intervention
P2860
Q33718454-D4361795-3218-4E40-817B-D0D95D97AF92Q33740654-307C69D9-C9A9-4C39-86A7-E5F9F44BC062Q37656277-91EDB672-5B74-45F0-A52E-86E5AE54EA9DQ37729235-50A285B1-2562-4C2F-B4EB-298EF09881B7Q38556918-FF3932C5-478A-4B90-93EE-A01C6BFFE06AQ38617000-F786B99A-7A68-4D9F-BF82-C49C16ED1C83Q38670012-235DEDD7-B56D-411B-96D7-98B20F866BBFQ39012371-C2158F3B-A00C-410C-BD02-87A244943DD4Q39263834-66E82990-45A8-45DD-BD9F-A5B7FC0E8730Q39327711-8BC51A9A-1741-4DA8-92F5-EBE7DE654119Q42512130-4686FFB6-A60F-45E3-AD15-E1D27ED682FFQ43721606-404AF282-C963-4890-A5A0-EDE04B555278Q47108252-09D3AE90-AE5A-466F-9A49-BD7B9FC52856Q47548797-4F114E64-5A92-44D5-8EEE-A72A41B361E7Q48129166-8BE72ED6-B73A-45F9-B2DF-B1DABD32C275Q51182174-4E702931-BD27-475A-A816-47C6924A338DQ52640400-368D7A34-EE6A-427A-A4A9-BFF4F172133FQ54942358-6A3A550B-8CEC-4D44-846F-00E665A74B79Q54960390-BE99B63C-FEBE-43A1-ADCE-760692D556DDQ57490914-F50A0239-9264-44E6-B71E-2E001DF25FA4Q58614424-01EA095A-6EC7-4245-A040-A3AF4EF2F9C9Q58799080-979C6891-B943-4423-9B4E-123E52FA8621
P2860
Microglial phenotypes in Parkinson's disease and animal models of the disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Microglial phenotypes in Parkinson's disease and animal models of the disease.
@en
type
label
Microglial phenotypes in Parkinson's disease and animal models of the disease.
@en
prefLabel
Microglial phenotypes in Parkinson's disease and animal models of the disease.
@en
P2093
P2860
P1476
Microglial phenotypes in Parkinson's disease and animal models of the disease.
@en
P2093
Anna R Carta
Giovanna Mulas
Valerie Joers
P2860
P356
10.1016/J.PNEUROBIO.2016.04.006
P577
2016-04-20T00:00:00Z